High throughput sequencing from Roche

By External Press Release Author
Monday, 11 June, 2007


Roche Diagnostics has launched the second generation of its high throughput sequencing technology, the Genome Sequencer FLX System.

Expanding upon the proven GS 20 System, over 100 million bases can be generated per 7.5-hour instrument run, with reads averaging 200 to 300 bases - ideal for a wide range of applications including amplicon resequencing, transcriptome analysis, gene regulation studies, and comparative genome sequencing.

Australia's largest genomics services company, the Australian Genome Research Facility, has the first Roche Genome Sequencer FLX system in Australia.

AGRF's acquisition of the Genome Sequencer FLX will complement current Sanger-based sequencing and bioinformatics services to deliver cutting edge sequencing technology to the Australian genomics research and industry sectors.

Please contact Tony Feneziani on 0448 864 095 for details of the services that AGRF offers.

Roche Diagnostics Australia

Related Articles

A neuroscientist and biochemist's antiviral lightbulb moment

While studying how certain processes work inside the human brain, an Australian scientist...

Antimicrobial resistance in children rises globally — 100K+ samples reveal

Spanning 82 countries, there was an increase in every region between 2004 and 2022, with the...

Robotic laboratory to fast-track drug invention, trials and commercialisation

The lab will house an automated system for high-throughput X-ray crystallography, often referred...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd